Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06428240Not Yet Recruiting

Acute Mesenteric Ischemia, Reality in Catalonia

Role: collaborator

NCT05871528Unknown

Registry of Patients With Remote Posterior cErebral Hemorrhage Following Reperfusion Treatment in Ischemic Stroke

Role: collaborator

NCT04623177Completed

Thromboprophylaxis for Patients in ICU With COVID-19

Role: collaborator

NCT04717947Unknown

Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS)

Role: collaborator

NCT03616561Completed

Quality of Life and Ultrasonographic Assessment of Nail Psoriasis After Treatment With Apremilast (JUST Study)

Role: collaborator

NCT03803891Unknown

Endoscopic Full-Thickness Resection In Colon

Role: collaborator

NCT02620358Not ApplicableCompleted

Two Opposite Strategies of Weaning From Mechanical Ventilation

Role: collaborator

All 7 trials loaded